Efficacy Study of Alanyl-glutamine Supplementation for the Treatment of C. Difficile Infection
Status:
Terminated
Trial end date:
2017-04-05
Target enrollment:
Participant gender:
Summary
The aim of this study is to test the efficacy of alanyl-glutamine supplementation in the
treatment of C. difficile infection. We hypothesize that alanyl-glutamine when given with
standard antibiotic treatment for C. difficile infection will decrease diarrhea, mortality
and recurrent disease.